IS5675A - Homogeneous formulations of abacavir, lamivudine and zidovudine - Google Patents
Homogeneous formulations of abacavir, lamivudine and zidovudineInfo
- Publication number
- IS5675A IS5675A IS5675A IS5675A IS5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A IS 5675 A IS5675 A IS 5675A
- Authority
- IS
- Iceland
- Prior art keywords
- abacavir
- lamivudine
- zidovudine
- homogeneous formulations
- formulations
- Prior art date
Links
- LHCOVOKZWQYODM-CPEOKENHSA-N 4-amino-1-[(2r,5s)-2-(hydroxymethyl)-1,3-oxathiolan-5-yl]pyrimidin-2-one;1-[(2r,4s,5s)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione Chemical compound O=C1N=C(N)C=CN1[C@H]1O[C@@H](CO)SC1.O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](N=[N+]=[N-])C1 LHCOVOKZWQYODM-CPEOKENHSA-N 0.000 title 1
- 229960004748 abacavir Drugs 0.000 title 1
- MCGSCOLBFJQGHM-SCZZXKLOSA-N abacavir Chemical compound C=12N=CN([C@H]3C=C[C@@H](CO)C3)C2=NC(N)=NC=1NC1CC1 MCGSCOLBFJQGHM-SCZZXKLOSA-N 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Inorganic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Biophysics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809213.3A GB9809213D0 (en) | 1998-04-29 | 1998-04-29 | Pharmaceutical compositions |
| PCT/EP1999/002794 WO1999055372A1 (en) | 1998-04-29 | 1999-04-26 | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5675A true IS5675A (en) | 2000-10-20 |
Family
ID=10831228
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5675A IS5675A (en) | 1998-04-29 | 2000-10-20 | Homogeneous formulations of abacavir, lamivudine and zidovudine |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP1083932A1 (en) |
| JP (1) | JP2002512979A (en) |
| KR (1) | KR20010043128A (en) |
| CN (1) | CN1411380A (en) |
| AP (1) | AP2000001971A0 (en) |
| AU (1) | AU4135599A (en) |
| BR (1) | BR9910071A (en) |
| CA (1) | CA2330391A1 (en) |
| EA (1) | EA200000997A1 (en) |
| EE (1) | EE200000646A (en) |
| GB (1) | GB9809213D0 (en) |
| HR (1) | HRP20000732A2 (en) |
| HU (1) | HUP0101622A3 (en) |
| ID (1) | ID26955A (en) |
| IL (1) | IL139181A0 (en) |
| IS (1) | IS5675A (en) |
| NO (1) | NO20005418L (en) |
| NZ (1) | NZ507745A (en) |
| PL (1) | PL343710A1 (en) |
| SK (1) | SK16212000A3 (en) |
| TR (1) | TR200003157T2 (en) |
| WO (1) | WO1999055372A1 (en) |
| ZA (1) | ZA200005922B (en) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU4219799A (en) * | 1998-05-29 | 1999-12-13 | University Of Florida | Combination therapy for treatment of fiv infection |
| US6875773B1 (en) | 1998-05-29 | 2005-04-05 | Ben M. Dunn | Combination therapy for treatment of FIV infection |
| GB9820417D0 (en) * | 1998-09-18 | 1998-11-11 | Glaxo Group Ltd | Antiviral combinations |
| US7074417B2 (en) * | 2000-10-13 | 2006-07-11 | Advancis Pharmaceutical Corporation | Multiple-delayed release anti-viral product, use and formulation thereof |
| AU2002311622A1 (en) * | 2002-04-23 | 2003-11-10 | Lupin Limited | Long acting compositions comprising zidovudine and lamivudine |
| TW200403061A (en) * | 2002-06-04 | 2004-03-01 | Glaxo Group Ltd | Pharmaceutical compositions |
| CN100335125C (en) * | 2003-06-03 | 2007-09-05 | 上海现代药物制剂工程研究中心 | Interferon nasal spray powder with long service for detoxication and anti-bacteria |
| WO2006114709A1 (en) * | 2005-04-25 | 2006-11-02 | Aurobindo Pharma Limited | Pharmaceutical compositions of antiretrovirals |
| US20070059360A1 (en) * | 2005-07-29 | 2007-03-15 | Ashish Jaiswal | Water-dispersible anti-retroviral pharmaceutical compositions |
| ES2279707B1 (en) * | 2005-11-10 | 2008-06-01 | Combino Pharm, S.L. | ORAL FORMULATIONS THAT INCLUDE 3'-AZIDONUCLEOSIDS. |
| US20110053884A1 (en) * | 2007-10-02 | 2011-03-03 | Schinazi Raymond F | Potent combinations of zidovudine and drugs that select for the k65r mutation in the hiv polymerase |
| US20110117193A1 (en) * | 2008-01-17 | 2011-05-19 | Duquesne University Of The Holy Spirit | Antiretroviral drug formulations for treatment of children exposed to hiv/aids |
| EP3351249A1 (en) * | 2010-01-27 | 2018-07-25 | VIIV Healthcare Company | Antiviral therapy |
| CN114010776A (en) | 2010-06-09 | 2022-02-08 | 疫苗技术股份有限公司 | Therapeutic immunization of HIV-infected persons for enhancing antiretroviral therapy |
| CA2866133A1 (en) | 2012-03-05 | 2013-09-12 | Cipla Limited | Pharmaceutical antiretroviral combinations comprising lamivudine, festinavir and nevirapine |
| EP2911674A1 (en) | 2012-10-23 | 2015-09-02 | Cipla Limited | Pharmaceutical antiretroviral composition |
| HUE066123T2 (en) * | 2013-06-13 | 2024-07-28 | Akebia Therapeutics Inc | Compositions and methods for treating anemia |
| CN117618453A (en) * | 2022-08-24 | 2024-03-01 | 安徽贝克制药股份有限公司 | Pharmaceutical compositions containing abacavir, zidovudine and lamivudine |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MY115461A (en) * | 1995-03-30 | 2003-06-30 | Wellcome Found | Synergistic combinations of zidovudine, 1592u89 and 3tc |
| GB9622681D0 (en) * | 1996-10-31 | 1997-01-08 | Glaxo Group Ltd | Pharmaceutical compositions |
-
1998
- 1998-04-29 GB GBGB9809213.3A patent/GB9809213D0/en not_active Ceased
-
1999
- 1999-04-26 TR TR2000/03157T patent/TR200003157T2/en unknown
- 1999-04-26 AP APAP/P/2000/001971A patent/AP2000001971A0/en unknown
- 1999-04-26 SK SK1621-2000A patent/SK16212000A3/en unknown
- 1999-04-26 CN CN99807983A patent/CN1411380A/en active Pending
- 1999-04-26 ID IDW20002479A patent/ID26955A/en unknown
- 1999-04-26 EE EEP200000646A patent/EE200000646A/en unknown
- 1999-04-26 PL PL99343710A patent/PL343710A1/en unknown
- 1999-04-26 WO PCT/EP1999/002794 patent/WO1999055372A1/en not_active Ceased
- 1999-04-26 KR KR1020007012021A patent/KR20010043128A/en not_active Withdrawn
- 1999-04-26 CA CA002330391A patent/CA2330391A1/en not_active Abandoned
- 1999-04-26 NZ NZ507745A patent/NZ507745A/en unknown
- 1999-04-26 EP EP99924822A patent/EP1083932A1/en not_active Withdrawn
- 1999-04-26 AU AU41355/99A patent/AU4135599A/en not_active Abandoned
- 1999-04-26 EA EA200000997A patent/EA200000997A1/en unknown
- 1999-04-26 BR BR9910071-1A patent/BR9910071A/en not_active IP Right Cessation
- 1999-04-26 JP JP2000545569A patent/JP2002512979A/en active Pending
- 1999-04-26 HU HU0101622A patent/HUP0101622A3/en unknown
- 1999-04-26 IL IL13918199A patent/IL139181A0/en unknown
- 1999-04-26 HR HR20000732A patent/HRP20000732A2/en not_active Application Discontinuation
-
2000
- 2000-10-20 IS IS5675A patent/IS5675A/en unknown
- 2000-10-23 ZA ZA200005922A patent/ZA200005922B/en unknown
- 2000-10-27 NO NO20005418A patent/NO20005418L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002512979A (en) | 2002-05-08 |
| EE200000646A (en) | 2002-04-15 |
| HUP0101622A2 (en) | 2002-03-28 |
| WO1999055372A1 (en) | 1999-11-04 |
| HRP20000732A2 (en) | 2001-02-28 |
| EA200000997A1 (en) | 2001-06-25 |
| NO20005418L (en) | 2000-11-29 |
| GB9809213D0 (en) | 1998-07-01 |
| AU4135599A (en) | 1999-11-16 |
| PL343710A1 (en) | 2001-08-27 |
| HUP0101622A3 (en) | 2003-09-29 |
| SK16212000A3 (en) | 2001-07-10 |
| IL139181A0 (en) | 2001-11-25 |
| EP1083932A1 (en) | 2001-03-21 |
| ID26955A (en) | 2001-02-22 |
| KR20010043128A (en) | 2001-05-25 |
| BR9910071A (en) | 2000-12-26 |
| NO20005418D0 (en) | 2000-10-27 |
| TR200003157T2 (en) | 2001-01-22 |
| CN1411380A (en) | 2003-04-16 |
| ZA200005922B (en) | 2001-10-23 |
| CA2330391A1 (en) | 1999-11-04 |
| NZ507745A (en) | 2004-07-30 |
| AP2000001971A0 (en) | 2000-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2325B (en) | Microplated formulations of eplerone | |
| NO20006520L (en) | adenosine | |
| DE59910409D1 (en) | distraction | |
| IS5555A (en) | Selekoxib formulations | |
| NO20004240L (en) | formulations | |
| DK1130966T3 (en) | Antiparasitic formulations | |
| PT1139761E (en) | HERBICID AND CONCENTRATED COMPOSITIONS | |
| DE69911530D1 (en) | Curable silicone composition | |
| DE69908455D1 (en) | inserter | |
| NO20004160L (en) | Cross country or cross country skiing | |
| NO20005418L (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| DE69936800D1 (en) | mass spectrometry | |
| NO981187L (en) | Slagm ° lle | |
| IS5024A (en) | Pharmaceutical formulations containing lamivudine and zidovudine | |
| DE69840421D1 (en) | PARTICIPANTS CONTEXT | |
| ID28032A (en) | TRICICLIC OF PIPERIDIN-Δ3-AS ANTAGONIS-α2 | |
| DE59904423D1 (en) | combined instrument | |
| NO20011358L (en) | Antiviral combinations | |
| ID27962A (en) | MAKING TETRAHIDROFURAN | |
| DK1140068T3 (en) | DORAMECTIN FORMULATIONS | |
| DE69920604D1 (en) | Fluorinated blowing agent compositions | |
| ID26655A (en) | MAKING STREPTOKOKUS | |
| ATA191299A (en) | COATING MASS | |
| HK1034188A (en) | Homogeneous pharmaceutical compositions comprising abacavir, lamivudine and zidovudine | |
| DK1133300T3 (en) | Desmethylolanzapine Compositions and Methods |